see if it can work as a public company. charles: i think my head is too big for their glasses. [laughter] i don't buy ipos, but that one i might. by the way, ocean power tech, i had to buy shares for myself today, full disclosure, we'll see what happens there. in the meantime, liz claman, over to you. [laughter] liz: don't be jealous, charles, my warby parkers -- [laughter] you're hilarious. charles: you don't have any war by parkers. [laughter] liz: i do, are you kidding me? the guy who founded it is a berkeley graduate. go, bears. all right, on wall street as this hour as the bulls get spooked by quadruple witching, multiple futures and options on indexes and stocks all expire simultaneously. and as we head into the final hour, the dow is staring down

the third straight weekly loss. dow is down 165, s&p lower by 38, nasdaq down 164. it is all coming to a head literally just as the vote comes about by the food and drug administration committee on the pfizer booster shot. it's expected to take place at any minute. the fda panel, which is still discussing the issue right now, could decide whether the third covid vaccine shot is safe and effective. the mayo clinic's top vaccination expert, dr. gregory poland, is here on whoo he thinks will -- what he thinks will and should happen on this booster shot vote. plus, roaring kitty flexes his nine lives, he dodges a fine, but his former employer must pay a pretty penny. charlie gasparino has more on whether the roaring kitty settlement is really over or more to come. and a year ago may after 27 years of annual dividend hikes,

business at tangor factory outlets got so challenging due to the covid lockdowns that the company had to suspend its dividend. what a difference a year makes. on the hemos of last night's -- heels of last night's announcement that tangor is raising its dividend, the ceo is here on retail foot traffic. how good does it really look? it should give you a sense of what the stock can do in the future. as we said is, at any moment an fda advisory committee could vote to recommend the covid-19 vaccine booster to increase the immune systems of people 16 and older. so right now they're still discussing a full day of presentations on whether there's enough scientific evidence to show that such a shot is safe and efficacious. shares of pfizer and its german partner, biontech, have been pretty much trending lower. right now they are both down, pfizer lower by 1.33, biontech

by 3.5%. the scientists presented their evidence and opinions on the third jab. the white house saying earlier today it is prepared to roll out booster shots as early as next week depending on the fda's decision. to gerri willis who's been keyed into the fda's hearing all day long. what's at the center of the debate, i guess, that could swing one way or the other? >> reporter: it could. we're going to know in short order whether this particular panel okays the booster shot. but let me tell you, six and a half hours in, it's not at all clear what they want to do. but let me give you some takeaways here. lots of complaints about pfizer's application. it was based on studies of less than 400 people, that no young people were included and that the period of time studied super short, just a couple of months. her using data from israel -- they are using data from israel and other places. the fda has said haven't had time to independently verify some of these studies, but i

want to give you a sense of the conversation. so listen to what we've been hearing all day long. >> there is clear rogues of vaccine -- erosion of vaccine protection over time against covid-19, and emerging data indicates loss of protection against hospitalization. we need to maintain high vaccine effectiveness against covid-19 to contain the pandemic. >> the vaccine ises continue to maintain high protection against severe disease, hospitalization and death. however, it's difficult to distinguish the effects of increased time. >> reporter: all right. so you're hearing there the conversation going on. the first fella was william gruber from pfizer, the other, sarah oliver from the cdc. they're debating these topics. people are trying to decide how to vote, when to vote, when they have to vote later today.

the fda advisory committee meeting raising questions about why everyone should even have access to booster. shouldn't the booster be offered, they say, only to people with immune-compromised systems and the elderly? at the end of the day, the real takeaway here is that we are a long way from full government approvals. why? no matter what conclusions this committee comes to -- and let me tell you, they have long names -- booster approval will still be required to come from yet another fda committee, the advisory committee on immunization practices. and then, guess what? the cdc head has to approve it too. all right. so far we're only talking about the pfizer application if, right? moderna waiting in the wings. we don't have that one either yet. and even after all these boosters successfully just as the government has to decide how to distribute the thing, right? so in short, we're a long way from boosters. i know the white house wanted to get them in the marketplace as of the 20th, but it looks like

that's going to be super hard to do. liz, back to you. liz: yeah. the white house kind of had to back up a little bit because it came out swinging in august saying, you know, we're going to really start to push these booster shots early september. okay. so as we wait, and i want the assure our viewers that we will interrupt as soon as we get that information and be watching those stocks. while the fda vaccine committee debaits this outcome, let's -- debates this outcome, let's bring in dr. gregory poland, director of the mayo clinic vaccine research group. doctor, we're thrilled that you are here right now. can i just right off the bat ask you what you think the fda is going to vote today? >> well, really hard to know, but if you pushed me into a corner, my guess is that they will say, no, premature. particularly when you're including people all the way down to age 16. i could probably find my way there if we were talking about people 60, 65 and older or

people who had severe medical conditions, but the question they're being asked to vote on is everybody age 16 and older, and that's a bridge with too far given -- bridge too far given the data we have, i believe. liz: okay. well, let's talk about the data that we do have. i think that's rather significant that somebody who is so deeply understanding of what's going on, you yourself, are now saying that if you had to be pushed, the answer is no. what data do you believe they don't have that they really should have? as we understand it, pfizer gave a lot of, you know, data that wasn't exactly specific to the booster shot, but was more observational. what do you think? >> well, that's right. that refers to the type of clinical trial design that was done. i think the issues in regard to the data that they're presenting is it involved a little over 300 people. when you look at people age 65 and older, there were only 11 peoplen included in the studies

that they're presenting. they had varying study designs. these were exploratory analyses. they used assays to measure antibodies that are not validated. so you put all of that together, and you're sort of saying, well, we have hints in this direction certainly for infection, but the totality of the data are clear. these vaccines in a two-dose series are extremely effective against preventing death, hospitalization and severe disease. so the real question you end up asking is are they of value in preventing infection even though it might be asymptomatic or mild infection, and could it protect against transmitting the virus? and they don't have the answer to those two questions. liz: what did you glean from the much-discussed israeli effort and the israeli example? they gave their population boosters, and case rates went

down. we do know that israel has certainly seen another increase in cases just like the rest of the world due to the delta variant, but with your trained eye can you give us a sense of how you view what was happening in israel? >> you know, honestly, liz, it is a little confusing because the israeli data are very discrepe pant to what we've seen in the u.s., in scotland, in england, in canada. so why those differences. and it was actually the subject of one of the presentations. very likely these differences involved the fact that these are observational study designs. you're looking backwards at data and trying to extrapolate what the meaning of that is. but, you know, you looked at israel, it's a small country. they very rapidly rolled out their immunization, initial immune immunization plan, very homogeneous in many ways compared to the u.s.

so there's such significant differences that it's hard to take an observational study done in israel and then transplant that, if you will, into the u.s. and say, yeah, that's what's going to happen here. liz: fda's peter marks kicked off this meeting specifically by making what we all thought was a pretty interesting comment. he said as we proceed, i would ask that we do our best to focus on deliberations on the science related to the application under consideration and not, as he then put it, operational issues related to a booster shot. we interpreted that -- we, you know, "the claman countdown" team as we talked about it -- to say we can't be thinking right now about the ethical question, which is why is the united states going to give out a third shot when many underdeveloped or poorer countries haven't even gotten the first shot? doctor, where do you stand on that? because i know that you probably discuss ethics at the mayo clinic constantly. >> sure. you know, for us at the mayo clinic, our ethics center around

what is best for the population we're taking care of, and most importantly that patient in front of us. i think what dr. marks was signaling is that a there are concerns over countries that have no doses or are given very little, should we really be giving a third dose in order to sort of marginally decrease our own rates. that's one of the ethical questions. the other issue is do you really rule out in the middle of a pandemic where the real issue has been the large percentage of the population that has not been fully immunized? do you really rule out another massive public health immunization program under those conditions? liz: yeah. well, we are watching it very closely, and as we promised our viewers, we will interrupt as soon as the fda makes that decision which could come any moment from now. dr. poland, thank you very much -- >> my pleasure, liz.

liz: our thanks to the people at the mayo clinic. i need you guys to look at the vix, the volatility index. it is spiking, up about 10%, on a whole bunch of issues. the market's jittery. we've got market volatility, the fear index standing at 20.62, a gain of 10.5% right now. and some of it has to do with the fact that, yes, halloween still is over a month away, but one of the scariest events of the fall investing season is taking place literally right now. will quadruple witching put an evil spell on your portfolio -- [laughter] for the rest of september? or will markets break with history this time? our floor show traders up next on the moves you need to be making, they say, to guard your portfolio against any dark magic. closing bell 48 minutes away. the dow is losing 183. by the way, gold looks to be on track for a 2% loss this week. stay tuned, we're coming right back. ♪

♪

in 2016, i was working at the amazon warehouse when my brother passed away. and a couple of years later, my mother passed away. after taking care of them, i knew that i really wanted to become a nurse. amazon helped me with training and tuition. today, i'm a medical assistant and i'm studying to become a registered nurse.

in filipino: you'll always be in my heart. it's another day. and anything could happen. it could be the day you welcome 1,200 guests and all their devices. or it could be the day there's a cyberthreat. get ready for it all with an advanced network and managed services from comcast business. and get cybersecurity solutions that let you see everything on your network. plus an expert team looking ahead 24/7 to help prevent threats. every day in business is a big day. we'll keep you ready for what's next. comcast business powering possibilities.

♪ liz: breaking news, the pentagon says a u.s. drone strike in kabul last month that killed 10

civilians including 7 children was a mistake. this news coming out of this live news conference right now. now, the pentagon originally had said that the is strike killed 2 isis-k fighters believed to be involved in planning attacks against u.s. forces in kabul, but after a new york times investigation discovered that it was a civilian who was loading water into his car sister his family, now -- for his family, now the united states is saying it is unlikely that islamic state militants were killed in the strike in afghanistan. here is a look at how the defense stocks are moving. and, by the way, the reaper drone which pulled off that attack is made by general atomics aeronautical systems. but again, the news is this drone attack was made in error, and the pentagon now admitting as much. let us make a hard turn here. markets this friday are moving lower today. typically you would see something like that. you would see wild swings

because this kicks off a historically weak period for stocks. according to the stock trader's almanac, the s&p 500 has averaged a four-tenth of a percent decline during the month of december. that's the worst of any -- of september, that's the worst of any month, and much of it comes in the second half which, of course, begins next week. some of the volatility stems from quadruple witching and that, of course, is about to happen 50 something minutes from now, right? i mean, you're talking about quad witching which only a to occurs four times a year. it's the expiration of stock index futures, stock index futures options and futures. september's losses particularly happen from here on out, and checking this month, well, yeah, we are in the red with the dow down 2.25%, the s&p lower by a 2%, the nasdaq off by about 3.5%. but could this year be different? why? well, the federal reserve's open market committee has a crucial two-day meeting next week, could

be the most widely-followed meeting of the entire year, and on wednesday the fomc is expected to get the clearest clue yet as to when it will start tapering which is scaling back its $120 billion in monthly bond purchases. knowing that, will this september be different from the ones in the past? let's get right to our floor show traders because we don't know. tom hayes, chris robinson, i will start with you, tom. will this month be different particularly because you have that issue coming out from the fed next week, and that could gyrate things in one way or another. >> yeah. well, liz, a lot of people are talking about seasonality this year, and what we learned from experience is when everyone's looking for the same correction is when it often doesn't happen. we do think any pullbacks are going to be contained to 3-5% until the fed takes the pun. bowl away or start -- the punch bowl -- liz: which is when? >> we think more likely early

next year, earliest would be late this year, so the november meeting and probably implementation in december. and what we're going to see when they signal next week is that yields are going to continue to rise. the 10-year yield, just like in 2013 when they signaled in may and finally actually implemented in december, yields went up from 162 basis points to about 3% on the 10-year yield. i think we could see a move towards 2%. and that sets the stage for the reopening trade to come back. we're at an inflection point here, liz. value stocks' performance relative to growth over the summer have fallen to the lowest levels since last october right before the election. and we know what happened next. yields went up 100 basis points over the next five months, and value had one of its greatest outperformance periods from october through may of this year during that period. so next week there'll be no implementation, but i think there will be a signal. they're going to say we want to

move this ahead before year end if the data permits, and yields will start to climb. as a result, we want to take some profits on some of the tech stocks that have done well over the summer. we want to get some reopening exposure in anticipation of rising yields. we like cruise lines and we like airlines. norwegian cruise lines, their booking and pricing trends have been better than pre-pandemic of late for 2022, and united airlines -- even with dell that, the -- delta, the tsa numbers have been averaging 75% of pre-pandemic, and that's without largely business travel and international travel. that will are come back later this year and early next year as people get into offices. liz: chris, do you think that september will be different from the previous ones that the stock trader's almanac always references saying september's the ugliest month of the year? everybody thinks it's october. october's volatile, but september east really the worst -- september's really the worst on balance. where are you looking to invest

at this point when it comes to advising clients? >> well, the biggest thing is, you know, since the low of the panic 2020, we're up 109% in the s&p. if you pull up a chart of the s&p, a lot of people out there when you start talking about technicals, their eyes glade over, but there's some pretty -- glaze over. but there's some pretty good research in it. jack dreyfuss, he's an analysis guy, if you pull that chart up, you can see that we've been basically climbing that 50-day average since the recovery. so coincidentally, that that 50-day moving average is about a 2.5% correction, and the 100-day moving average is about a 5% correction, and the 200-day would be a 10 if correction. you've got everybody watching the same thing, and your first guest said the exact same thing. when everybody's talking about a correction, that's not when it happens. corrections come when nobody thinks it's going to happen, so

i'm happy to hear people say we're looking for a correction. that probably means it's not going to come. as for what the fed's going to do, it makes me think of -- and i raised a couple of kids, and when they're 2-3 years old, you've got to tell them it's time to go to bed. they're going to be told eight times, nine times before they do it. i wouldn't hold my breath. i watch the 10-year every day, we're sitting at 1.3%. the big bogeyman percentage is 2%. if it gets there, we'll see if that impacts stocks. liz: well, let me tell you, the nasdaq's taking the outsized hit right now, down about 1% or 151 points. a lot of people think stay in tech, that's the way to go, but we appreciate no matter what happens, you guys are with us to guide us. tom, chris, thanks very much. >> thanks, liz. liz: coming up, the stocks tied to the reopening trade that goldman sachs said a year ago to sell and was wrong about it. the tangor ceo, yes, of tangor

outlets, is coming right up. and they just hiked their dividends. he's here in a fox business exclusive with the closing bell ringing in 37 minutes. we do have the dow down 162 points, but we are up and ready for anything. stay tuned. "the claman countdown "with much more ahead. ♪ ♪ (vo) while you may not be a pediatric surgeon volunteering your topiary talents at a children's hospital — your life is just as unique. your raymond james financial advisor gets to know you, your passions, and the way you give back. so you can live your life. that's life well planned. let's go walter! after you. walter, twelve o' clock. get em boy! [cows mooing]

that is incredible. it's the multi-flex tailgate. it can be a step, it can even become a workspace. i meant the cat. what's so great about him? he doesn't have a workspace. the chevy silverado with the available multi-flex tailgate. find new adventures. find new roads. chevrolet.

the chevy silverado with the available multi-flex tailgate. find new adventures. all the time in the world. it's just a saying. but today, for women living with hr+, her2- metastatic breast cancer. more time is possible with verzenio. proven to help you live significantly longer when taken with fulvestrant. verzenio + fulvestrant is for hr+, her2- metastatic breast cancer that has progressed after hormone therapy. diarrhea is common, may be severe, or cause dehydration or infection. at the first sign, call your doctor, start and antidiarrheal, and drink fluids. before taking verzenio, tell your doctor about any fever, chills, or other signs of infection. verzenio may cause low white blood cell counts, which may cause serious infection that can lead to death. life-threatening lung inflammation can occur. tell your doctor about any new or worsening trouble breathing,

cough, or chest pain. serious liver problems can happen. symptoms include fatigue, appetite loss, stomach pain, and bleeding or bruising. blood clots that can lead to death have occurred. tell your doctor if you have pain or swelling in your arms or legs, shortness of breath, chest pain and rapid breathing or heart rate, or if you are nursing, pregnant, or plan to be. more time is possible. ask your doctor about verzenio. ♪ limu emu & doug ♪ got a couple of bogeys on your six, limu. they need customized car insurance from liberty mutual so they only pay for what they need. what do you say we see what this bird can do? woooooooooooooo... we are not getting you a helicopter. looks like we're walking, kid. only pay for what you need. ♪ liberty. liberty. liberty. liberty. ♪

♪ liz: i promised you we would break in if the fda advisory committee began voting, and they have. breaking news, the committee is voting on whether to recommend the pfizer covid-19 vaccine be used as a booster shot to increase the immune systems of people in the u.s. 16 years of age and older. right now based on the way the vote is going, it does sound likely they are leaning toward a no. booster approval still has to be given by the advisory committee on immunization practices and then the cdc chief has to

approve it. the white house had said is earlier today it is prepared to roll out booster shots as early as next week depending on the fda's decision. but, again, the main question here is does evidence show that the pfizer, specifically the pfizer booster shot, does the evidence show it is effective for those 16 years and older. as of right now the votes are not concluded -- wait, did it just say it's concluded? okay. that was an error on the screen. their screen, not ours. but for now, they are in the process of voting. we did just hear from dr. greg poland of the mayo clinic who said if he had to guess, he would believe the answer is no because the group, the test survey of people pfizer had used as their examples and as their data was only a made up of about 300 people. so, in the meantime, the second the actual vote comes through, we'll get it to you.

time now for your fox business brief. has the death of the spac merger been called too early? taking a look at the combo of soar eagle and bioworks, it might be. shares right now up 8%, but it's slipping all over the place. soaring eagle backed by harry sloan whose previous spacs helped take kraft kinks to the public market -- draftkings to the public market. flat on the session. zoom and 59 climbing today despite doubts over the company's planned merger. proxy adviser institutional shareholder services today recommending that 59 investors vote against that deal due to concerns over growth given zoom's recent decline. the vote is slated for september 30th. zoom, one of the nasdaq's top performers today, is up 2.8%,

five9 up 5%. thermal fisher, the scientific tool giant guided well above both profit and revenue estimates for 2022. up 7%, it's on track for a record close at nearly $600 a share. up next, forget gamestop and amc, what was it like for tangor's new ceo to watch his stock get the meme mania treatment? we're going to ask him next. ♪ ♪ it's another day. and anything could happen. it could be the day you welcome 1,200 guests and all their devices.

or it could be the day there's a cyberthreat. get ready for it all with an advanced network and managed services from comcast business. and get cybersecurity solutions that let you see everything on your network. plus an expert team looking ahead 24/7 to help prevent threats. every day in business is a big day. we'll keep you ready for what's next. comcast business powering possibilities. incomparable design makes it beautiful. state of the art technology makes it brilliant. the lexus nx. experience the crossover in its most visionary form. experience amazing at your lexus dealer. ♪♪ (vo) the rule in business used to be, "location, location, location." now it's, "network, network, network."

so you need a network that's built right. verizon business unlimited starts with america's most reliable network. then we add the speed of verizon 5g. we provide security that's made for business and offer plans as low as $30 per line. more businesses choose verizon than any other network. we are open and ready for you. i order my groceries online now. shingles doesn't care. i keep my social distance. shingles doesn't care. i stay within my family bubble. shingles doesn't care. because if you've had chicken pox, you're already carrying the virus that causes shingles. in fact, about 1 in 3 people will develop shingles, and the risk only increases as you age. so what can protect you against shingles? shingrix protects. now you can protect yourself from shingles with a vaccine proven to be over 90% effective. shingrix is a vaccine used to prevent shingles in adults 50 years and older.

shingrix does not protect everyone and is not for those with severe allergic reactions to its ingredients or to a previous dose. an increased risk of guillain-barré syndrome was observed after vaccination with shingrix. the most common side effects are pain, redness, and swelling at the injection site, muscle pain, tiredness, headache, shivering, fever, and upset stomach. talk to your pharmacist or doctor about protecting yourself with shingrix. shingles doesn't care. but we do. you booked a cozy vrbo mountain cabin. [laughs] with a kitchen where everyone can chef. [laughs] a family room where you can let your hair down. and a backyard that is a tree-lined living room. but the thing they'll remember forever? watching the game together once again. ♪♪ the time for getting back together is now. ♪♪ find it on vrbo.

hearing is important to living life to the fullest. that's why inside every miracle-ear store, you'll find a better life. it all starts with the most innovative technology. like the new miracle-earmini, available exclusively at miracle-ear. so small that no one will see it, but you'll notice the difference. and now, miracle-ear is offering a thirty-day risk-free trial. you can experience better hearing with no obligation. call 1-800-miracle right now and experience a better life. ♪ liz: breaking right now, it is a

no. the fda advisory committee has just voted not to recommend the pfizer covid-19 vaccine be used as a booster shot for now. 16 of the 18 panelists voted against the question, but the fda did say that the committee could propose modified voting questions in the future. we did ask the mayo clinic's dr. gregory poland at the top of the show what he thought would happen. here's what he told you and us at the top of the hour. >> my guess is that they will say no, premature. particularly when you're including people all the way down to age 16. i could probably find my way there if we were talking about people 60, 65 and older or people who had severe medical conditions, but the question they're being asked to vote on is everybody age 16 and older, and that's a bridge too far given the data we have. liz: right. so they're looking for more

data. if we look at pfizer and biontech stock, look at the intraday of pfizer. it did dip to its session low, it's barely off that, down about 1.6%. session low was a loss of about 2%. biontech, its partner as you can see, also gyrated, it's till down about a 5%. still down about 5%. this was only, again, for the pfizer booster shot, but moderna shares are down 5% as well. all right. the rise of e-commerce and curbside pick-up during the pandemic and lockdowns led so many people to predict those would be the final nails in the coffins for malls and the stocks behind malls. but data is out defying that theory. according to palacer labs, mall visits this past july exceeded pre-pandemic levels from two years ago. the increase in foot traffic giving significant boosts year to date to the likes of -- simon property group up 54%, but it's

tangor outlets showing the biggest spike if, up 75%. tangor is the largest listed outlet in the u.s. with more than 13 million square feet of space. finish in a bid to diversify, it has altered in the last year its dna adding new tenants such as a whiskey distillery and a gourmet grocer, and late yesterday the company announced a hike in its quarterly dividend to 18 cents a share n. a fox business exclusive, ceo stephen yalof is joining us live. stephen, welcome. the stock getting a nice bump earlier from that dividend declaration which is about a 2.8% increase. forking tangor had to suspend at the height of the lockdowns, what can investors assume from this dividend range in. >> first of all, i think it speaks to the fact that bricks and mortar retail back in

fashion. folks are shopping. sales are up and occupancy ises are rebounding from a year ago. liz: so what do you really attribute that? i know that people are dying to get out and go shopping, even people who don't like to shop, they're just so eager. on the other hand, we know that economically this country has taken a pretty significant hit, so they're looking for deals, and they are looking for bargains. you seem the check both of those boxes, but you're doing more these days. >> well, we also tap the open air box, and i think that's something that's very important to the consumer right now. our shopping centers are open air, they're safe and comfortable places for a lot of people the gather. a year ago when there were very few gathering places, people were looking for places to get together, and and our open air shopping centers provided that venue. what we've learned from covid is not only do our shoppers, our outlet shoppers look for great

value for the best brands, but they're also looking for a place to spend time. they're looking for great amenities. they're looking for great experiences and also entertainment. and as you talked earlier about some of the changes that we're making to the dna of tanger, changing some of those factors is something that we're leaning very heavily into going forward. liz: many of your outlets are located near vacation destinations, hilton head, for example, or the hamp stomps. so what you've -- hamptons. instead of just offering gap at a discount, you've also put in, as we said, a whiskey distillery, there's a fancy fish restaurant, i understand, now in hilton head. can you tell us the partnerships you're looking to have in order to lure more foot traffic? >> sure. you know, typically outlet centers have been very reliant on footwear, on apparel and on accessories. at great value.

but now what we're finding is our customers are looking for much more. they're looking for a much higher experiential opportunity when they come and shop with us. so a picture of nantucket meat and fish, that's a gourmet grocer from nantucket island that has positioned themselves in our shopping center in south carolina. and one of the great boosts that we're seeing is typically when people shop an outlet center, particularly when they're in a geography like hilton head, you find that customer might come once, maybe twice during their stay. now that we've added this upscale gourmet grocer, not only are we finding a new customer, we're finding them come and shop with us more frequently. and that's something that we're looking for. developing new customers, getting them to shop with us more frequently, getting them to spend more time when they're there and, obviously, build bigger baskets and, ultimately, drive higher sales. liz: it has been wild, and i'm

talking this year, forget about last year. march 9th, goldman sachs had said, you know what? this stock has rub up too far, too fast or -- run are up too far, too fast. march 9 9th i think called it a sell and had a price target9 of about $12.50. it did take a hit on that call, but you -- for a brief shining moment, you were a meme stock. you got named because you were heavily shorted by wall street in the wall street bets reddit crowd. and and to me, i thought that was really interesting because the stock became sort of jerked around on a leash by all kinds of different forces. what was that a like during that time, and how did you handle something like that? >> well, we were set up very well. we had an atm in place which gave us an opportunity to raise capital in the marketplace, and we certainly didn't take the wild ride that a lot of the other so-called people stocks did, but we did see a quick runup in our stock and were able

to take advantage of that by executing to our atm at that time. liz: nice. well, it's really nice to see that you guys have the dividend and you're not only free instituting it, but now you're hiking it. stephen yalof of tanger outlets, thank you so much for coming on exclusively. >> thank you for having me. liz: the cat is out of the bag when it comes to, speaking of meme stocks, roaring kitty's meme mania moves, and it's a costly one for one investment firm. we're talking about the fallout created by the leader of the gamestop reddit rebellion. and what a story when it comes to kenzie capital. haven't herald of it? it is a private equity outfit in chicago founded by suzanne yoon who immigrated to the u.s. at a young age. great immigrant story here. she restocked shelves at age 6,

but after her father was murdered one night and tragedy befell the family, suzanne, well, she just got ready x she's charged for success. trailblazing the finance industry, building her own private equity firm and now creating hundreds of jobs each time she buy withs a new company. if all right, listen on spotify, google and apple. closing bell, we're 17 minutes away. we are coming right back. dow is down 164. ♪ ♪ ♪ music playing. ♪ there's an america we build ♪ ♪ and one we explore one that's been paved and one that's forever wild but freedom means you don't have to choose just one adventure ♪ ♪

you get both. introducing the all-new 3-row jeep grand cherokee l jeep. there's only one. that building you're trying to sell, jeep grand cherokee l - you should ten-x it. - ten-x it? ten-x is the world's largest online commercial real estate exchange. you can close with more certainty. and twice as fast. if i could, i'd ten-x everything. like a coffee run... or fedora shopping. talk to your broker. ten-x does the same thing, - but with buildings. - so no more waiting. sfx: ding! see how easy...? don't just sell it. ten-x it.

in business, it's never just another day. it's the big sale, or the big presentation. the day where everything goes right. or the one where nothing does. with comcast business you get the network that can deliver gig speeds to the most businesses and advanced cybersecurity to protect every device on it— all backed by a dedicated team, 24/7.

every day in business is a big day. we'll keep you ready for what's next. comcast business powering possibilities. ♪ limu emu & doug ♪ [ emu grunts ] got a couple of bogeys on your six, limu. they need customized car insurance from liberty mutual so they only pay for what they need. what do you say we see what this bird can do? woooooooooooooo... we are not getting you a helicopter. looks like we're walking, kid. only pay for what you need. ♪ liberty. liberty. liberty. liberty. ♪ the comfortable way to work out. -that looks fun actually. -looks like a paisley. -hey, a paisley, we'll take it. -yeah. oh my god, i could do this and watch tv at the same time. -exactly! -fantastic. oh yeah, i can do this. this is easy. and definitely better than the floor. -it feels sexy. -it feels good.

i want this in my house. (host) wondering if the aerotrainer is tough? (engine revving) ♪ liz: well, the wall street bets/reddit crowd is cheering on one of their own at hour after roaring kitty, the investor credited with turning gamestop into a meme stock way back when, dodged punishment while his

former employer, mass mutual, got tossed into the lions eden. massachusetts regulators fining them $4.75 million for, quote, failing to supervise the activity of its agents including one roaring kitty himself, keith gill, the trader and reddit persona who helped fuel gamestop's meteoric rise. his wall street betts posts and youtube posts which helped send gamestop surging by as much as 400% back in january were all made as he worked as employee of a mass mutual subsidiary. massachusetts regulators are still investigating the trader himself for his role in the gamestop frenzy, but for now he dodged it, confirming via reddit at the height of the trade in january he was up more than 4,000% -- [laughter] to $48 million on his reddit can investments. gamestop today is down slightly, but look at it year-over-year, up -- sorry, this year, up 998%,

and if you just flip it over the a one-year chart, those gains more than double to, as you can see, a very dramatic move here of more than -- let me just quickly check, because i want to make sure i got this right -- 7, well, year-over-year? i'm looking at amc. gamestop, year-over-year, we do have that one up 2,279%. i told you it was important, right? well, the gamestop and roaring kitty fallout the main topic of my red fox liz tiktok post today, and if a bunch of you bared your digital claws, so far thrilled gill has escaped punishment. one said, quote, massive pump and dumps are done every day, they just don't like retail investors doing it. another, so senators can trade on inside info, but a guy can't recommend stocks?

another, quote, it was a great move, let's be real. it showed how the people still have some power. and, look, you cannot deny the retail investors banded together. i want to bring in charlie gasparino who's been all over it from the start and the significance of this massachusetts ruling. here's another one, when government gets involved, fair is not a word i would use. on balance, they're saying that all keith gill did was what a lot of people on wall street have done for so long. >> i mean, i don't think that for a fact. we should point out he's still under investigation. i will say the guy's are a registered investment adviser. he's no longer working at mass mutual, was he fired? liz: no, no, he left. he left of his own volition. >> he was making enough money, obviously. as a registered investment adviser, he's potentially allowed to advise people to invest in stocks, so i don't know what the case could be

other than, you know, something -- i mean, just superficially there's no case here against him. i mean, he's a registered investment adviser, he advised a few people -- three, from what i understand -- to do certain things. he posted tough on reddit about his trades. unless he was doing the opposite of what he was posting, maybe showing some sort of manipulation case -- liz: exactly. >> -- there's really nothing here. and so the guy is fine. and that's the whole thing. the one question is, i think, with all these meme stock guys and everything, you know, listen, to invest in a stock purely for a short squeeze is dicey particularly if you're telling people there's going to to be a short squeeze like the amc apes do and the stock is going to a hundred when there's no evidence that amc is ever going to squeeze. and one of the reasons why there's no evidence, because it's easy to borrow the stock. if you tell people that, there could be a case -- and i've said

this in the past -- of you trying to jack up the price of a stock based on false information because there's no information here, there's nothing out there that lets anybody believe that amc is ripe for a short squeeze anytime soon. it's easy to borrow. prices are going down lately, so it just tells you after it kind of broke out at 50 and then it died. the squeeze didn't occur. there's not -- you know, we should point out that most hedge funds are very modestly short stocks. they don't go nuts shorting stocks. this is -- you've got to be real careful here, and here's where it gets dicey, liz. you know, let me finish this. you read all these guys' comments, let me just say a what i'm saying, because this is important. you tell people there's going to be a short squeeze and they buy at 70 thinking it's going to go to 100 and it doesn't happen, guess what? the people at 50 start selling. and then that's when this thing

cascades down because the fundamentals of amc clearly are not reflected in the stock price. i think adam aron is doing a great job as ceo, he's a smart guy. i want his business to survive and succeed is, but, you know, there's a lot against it. but this whole notion of a short squeeze which these guys are playing around with these terms and trying to get people in the stock, they're playing with fire. this could be market manipulation, particularly if one doesn't have it. ♪ liz: charlie, i am back in studio for the first time in 18 months -- i'll -- >> i'll be there monday. i'll be on the set with you on monday. [laughter] the first time in -- liz: charlie gasparino, liz claman, the team is back together. you've got to tune in monday. we are coming right back. don't go away. ♪ ♪ -well, audrey's expecting... -twins! grandparents!

we want to put money aside for them, so...change in plans. alright, let's see what we can adjust. ♪♪ we'd be closer to the twins. change in plans. okay. mom, are you painting again? you could sell these. ...

what makes new salonpas arthritis gel so good for arthritis pain? salonpas contains the most prescribed topical pain relief ingredient. it's clinically proven, reduces inflammation and comes in original prescription strength. salonpas. it's good medicine. [slow electronic notes fade in] [fast upbeat music begins] [music stops] and release. [deep exhale] [fast upbeat music resumes]

[music stops] as i observe investors balance risk and reward, i see one element securing portfolios, time after time. gold. your strategic advantage.

liz: three and a half minutes out from the closing bell major indices slipping today and for the week, all three indices will close in the red. china's crackdown on macau casinos sending wynn resorts to the bottom of the s&p 500 this week but oils rally above $73 per barrel propelling diamondback energy to the top of the s&p 500 weekly leaderboard. okay folks we just talked about tanger outlets but we know that e-commerce has gone absolutely nuts in the last year and a half our countdown closer has the two names he says can give you the most massive exposure before the holiday season, pence capital management has it. go for it what are they? >> hi, liz thank you very much. it's great to see you. liz: thank you. >> basically, the big ones here are amazon and shopify. you had amazon and shopify, you're basically getting about 47% of all of the involvement in

e-commerce going to the united states, and christmas is coming and that's really important. liz: yeah, hanukkah too, and all of the holidays because you look at shopify has just been amazing has it not? >> one of the big things that we have to pay attention to is that when you have all the ports on the west coast that are basically blocked right now, or very slow right now, you're not going to have this huge inventory, so people should do their christmas shopping now, and they should be focusing on that, because they are going to be doing either online or in- person, and i don't think there's going to be a lot of sales. there's tremendous amount of money in the economy, we've pump ed 5.4 trillion into it, consumers have about 2.7 in money in their banks, of excess savings and that's going to drive a lot of demand cycle and that means that you're not going

to see as many sales at the end. things aren't going to go on sale you need to do your shopping now, online. liz: great to have you, >> [ closing bell ringing] liz: the crew of spacex's inspiration for all civilian crew in space, ringing the new york stock exchange's closing bell from space, take a look at it, wow that'll do it for the "clayman countdown." larry: hello, everyone, welcome to kudlow, i'm larry kudlow. i want to begin tonight by going back to yesterday's budget speech by president joe biden. you may recall that on eight separate occasions, mr. biden referred to pay their fair share he just kept repeating it. i guess some left wing pollster probably told him that it'll play well in progressive precincts. now, as you may have guessed this performance and its content